✕
Monday, April 6, 2026
Breaking
New ‘Liquid Biopsy’ Blood Test Detects Heart Failure Risk Five Years Before Symptoms Develop·Liquid Biopsy Detects 12 Cancer Types From a Single Blood Draw With 89% Accuracy·Statin Use in Adults Over 75 Reduces Heart Attack Risk by 28%, Largest-Ever Meta-Analysis Confirms·New Blood Test Detects Parkinson’s Disease Up to 7 Years Before Symptoms Appear·Wearable ECG Patches Detect Atrial Fibrillation With 94% Accuracy in 30-Day Monitoring Study·New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 Trial·WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three Countries·New ‘Liquid Biopsy’ Blood Test Detects Heart Failure Risk Five Years Before Symptoms Develop·Liquid Biopsy Detects 12 Cancer Types From a Single Blood Draw With 89% Accuracy·Statin Use in Adults Over 75 Reduces Heart Attack Risk by 28%, Largest-Ever Meta-Analysis Confirms·New Blood Test Detects Parkinson’s Disease Up to 7 Years Before Symptoms Appear·Wearable ECG Patches Detect Atrial Fibrillation With 94% Accuracy in 30-Day Monitoring Study·New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 Trial·WHO Declares H5N1 Bird Flu a Public Health Emergency After Human-to-Human Transmission Confirmed in Three Countries·
Tag

universal flu vaccine

New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 TrialInfectious Disease

New mRNA Vaccine Provides 94% Protection Against All Major Influenza A Subtypes in Phase 3 Trial

Dr. Priya NairMar 13, 2026 · 2 min read